COMING NEXT:

Scientific Spotlights

The EADV Scientific Spotlights are a collection of expert insights and updates across various fields of dermatology and venereology.
Selected from our events, podcasts, and various academy activities, our Scientific Spotlights bring you the latest developments and in-depth discussions led by renowned specialists in dermatovenereology.

hair disease eadv symposium session
Symposium 2025

Hair and nail disorders

Skin, hair, and nails reveal systemic diseases. This session covers hair and nail signs in lupus, cancer, and cardiovascular issues. Hair loss patterns may indicate SLE or malignancies, while nail changes like clubbing or Beau’s lines signal systemic illness. Early recognition aids diagnosis and treatment. Another session focuses on nail dystrophy, stressing accurate diagnosis for effective care.

Podcast

EADV Podcast ep. 131 – Editor’s Picks February 2025

Join Dr. Christian Posch, JEADV Associate Editor, presenting his selection of Editor’s Picks from the February 2025 issue:
(1) Navigating healthcare with atopic dermatitis: analysing patient journeys in Germany
(2) Characterization of patients with atopic dermatitis based on flare patterns and severity of disease: a Danish population-based study
(3) An international study of steroid-induced myopathy in autoimmune blistering diseases

Congress 2024

Unveiling the Pathomechanism of Behçet’s Disease

EADV funded
Behçet’s disease (BD) is a chronic, relapsing multisystemic vasculitis that typically affects individuals in their 30s and 40s, leading to significant morbidity. Its pathogenesis remains enigmatic, shaped by complex genetic, environmental, autoimmune, and autoinflammatory factors.

Podcast

EADV Podcast ep. 129 – Editor’s Picks January 2025

Join Prof. Carle Paul presenting his Editor’s Picks of January 2025:
(1) Latent Tuberculosis and biological agents
(2) Dermoscopy combined with reflectance confocal microscopy for amelanotic melanoma
(3) Adalimumab drug survival in Hidranetis Suppurativa
(4) Does acne impact the use of dating applications?

hair disease eadv symposium session
Symposium 2025

Hair and nail disorders

Skin, hair, and nails reveal systemic diseases. This session covers hair and nail signs in lupus, cancer, and cardiovascular issues. Hair loss patterns may indicate SLE or malignancies, while nail changes like clubbing or Beau’s lines signal systemic illness. Early recognition aids diagnosis and treatment. Another session focuses on nail dystrophy, stressing accurate diagnosis for effective care.

Congress 2024

Unveiling the Pathomechanism of Behçet’s Disease

EADV funded
Behçet’s disease (BD) is a chronic, relapsing multisystemic vasculitis that typically affects individuals in their 30s and 40s, leading to significant morbidity. Its pathogenesis remains enigmatic, shaped by complex genetic, environmental, autoimmune, and autoinflammatory factors.

Congress 2024

Use of mohs surgery in non-keratinocytic tumours

Mohs micrographic surgery (MMS) is the gold standard for basal and squamous cell carcinomas and is increasingly used for non-keratinocytic tumors, including melanomas like lentigo maligna melanoma (LMM) and melanoma in situ (MIS). MMS offers precise cancer removal, but its use for deeper melanomas is still controversial and requires more research.

Congress 2024

Dermoscopy of melanoma

Histology is the gold standard for melanoma diagnosis, but excising all suspicious lesions is costly. Imaging methods like RCM and LC-OCT are less invasive but expensive, limiting their use. Dermoscopy, however, is affordable and effective, improving diagnosis while reducing unnecessary excisions. This lecture uses images to teach key dermoscopic features of melanocytic lesions and melanoma, covering common pitfalls and special areas like the face and mucosae.

Congress 2024

Melanoma in children

Pediatric cutaneous melanoma is rare, comprising 1% of childhood cancers. It often differs from adult cases, sometimes linked to large congenital nevi. Its rarity and unique traits complicate diagnosis and treatment, emphasizing the need for more research to improve outcomes.

woman looking at her nails
Congress 2024

Psoriasis and lichen planus in nails

Nail psoriasis and lichen planus are chronic conditions affecting nails and quality of life. Psoriasis shows pitting and onycholysis, possibly needing rheumatologist referral for arthritis. Lichen planus causes ridging and potential permanent damage, requiring early treatment. Treatments include topical and systemic therapies, with future options like JAK inhibitors.

clinical tests on drugs
Congress 2024

Psoriasis – Therapeutic drug monitoring in your practice?

Psoriasis treatments now include biologics targeting TNF-α, IL-17, and IL-23, but patient response varies. Some patients do not respond or lose response, while others achieve near-complete skin clearance, allowing dose reduction. Clinicians are optimizing doses empirically and investigating this for newer biologics. Therapeutic drug monitoring (TDM) measures drug levels and anti-drug antibodies, helping guide treatment based on exposure-response relationships, which have been identified for newer biologics.

Podcast

EADV Podcast ep. 131 – Editor’s Picks February 2025

Join Dr. Christian Posch, JEADV Associate Editor, presenting his selection of Editor’s Picks from the February 2025 issue:
(1) Navigating healthcare with atopic dermatitis: analysing patient journeys in Germany
(2) Characterization of patients with atopic dermatitis based on flare patterns and severity of disease: a Danish population-based study<br

Podcast

EADV Podcast ep. 129 – Editor’s Picks January 2025

Join Prof. Carle Paul presenting his Editor’s Picks of January 2025:
(1) Latent Tuberculosis and biological agents
(2) Dermoscopy combined with reflectance confocal microscopy for amelanotic melanoma
(3) Adalimumab drug survival in Hidranetis Suppurativa
(4) Does acne impact the use of dating applications?

anti acne cream
Position statements

Position statement on latest study regarding benzene in Acne products

Press Release from EADV’s Acne, Rosacea and Hidradenitis Suppurativa Task Force
Benzene, a highly volatile chemical, poses significant health risks, classified as a Group 1 carcinogen by IARC. Exposure occurs through various sources, including industrial emissions, tobacco smoke, and contaminated cosmetics. Recent findings of benzene in anti-acne products raise concerns,